NOV

National Oilwell Varco Provides Operational Update for the First Quarter 2019

Retrieved on: 
Friday, April 12, 2019
Energy, Oil, Gas, Other Energy, NOV, National Oilwell Varco, Varco, New York Stock Exchange, Companies, Economy of the United States, Economy of New York City

National Oilwell Varco, Inc. (NYSE: NOV) today announced that it expects to report first quarter 2019 revenues of $1.94 billion, which is below prior expectations.

Key Points: 
  • National Oilwell Varco, Inc. (NYSE: NOV) today announced that it expects to report first quarter 2019 revenues of $1.94 billion, which is below prior expectations.
  • These dynamics translated into order intake that accelerated through the quarter and resulted in a sequential increase in bookings.
  • Notwithstanding our expectations for market conditions and our financial results to improve as we progress through 2019, the outlook remains opaque.
  • NOV will hold its first quarter 2019 conference call on Friday, April 26 at 10 a.m. (Central Time).

Cerapedics Announces ISASS Bone Grafting Policy Statement Features i-FACTOR™ Peptide Enhanced Bone Graft

Retrieved on: 
Wednesday, March 6, 2019
Medical specialties, Medicine, Surgery, Transplantation medicine, Bone grafting, Oral and maxillofacial surgery, Immunology, Bone, NOV, T cell, Surface modification of biomaterials with proteins

"The ISASS statement notes that iFACTOR Peptide Enhanced Bone Graft is based on a well-established mechanism of action and carries extensive clinical data including level 1 human data that strongly supports its safety and efficacy."

Key Points: 
  • "The ISASS statement notes that iFACTOR Peptide Enhanced Bone Graft is based on a well-established mechanism of action and carries extensive clinical data including level 1 human data that strongly supports its safety and efficacy."
  • iFACTOR Peptide Enhanced Bone Graft has a novel mechanism of action (attract, attach, and activate) that induces osteoblast cell proliferation and differentiation to accelerate new bone formation in patients with degenerative disk disease.
  • Prior research indicates that iFACTOR Peptide Enhanced Bone Graft is superior to the historical "gold standard" autograft in overall clinical success.
  • i-FACTOR Peptide Enhanced Bone Graft is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process.

National Oilwell Varco Declares Regular Quarterly Dividend

Retrieved on: 
Friday, March 1, 2019
Energy, Oil, Gas, Other Energy, National Oilwell Varco, Varco, NOV, Companies, Merrill A. Miller Jr., Robbins & Myers

National Oilwell Varco, Inc. (NYSE: NOV) today announced that its Board of Directors declared the regular quarterly cash dividend of $0.05 per share of common stock, payable on March 29, 2019 to each stockholder of record on March 15, 2019.

Key Points: 
  • National Oilwell Varco, Inc. (NYSE: NOV) today announced that its Board of Directors declared the regular quarterly cash dividend of $0.05 per share of common stock, payable on March 29, 2019 to each stockholder of record on March 15, 2019.
  • National Oilwell Varco (NYSE: NOV) is a leading provider of technology, equipment, and services to the global oil and gas industry that supports customers full-field drilling, completion, and production needs.
  • Since 1862, NOV has pioneered innovations that improve the cost-effectiveness, efficiency, safety, and environmental impact of oil and gas operations.
  • Readers are referred to documents filed by National Oilwell Varco with the Securities and Exchange Commission, including the Annual Report on Form 10-K, which identify significant risk factors which could cause actual results to differ from those contained in the forward-looking statements.

National Oilwell Varco Announces First Quarter 2019 Conference Call

Retrieved on: 
Tuesday, February 19, 2019
Energy, Oil, Gas, Manufacturing, Other Manufacturing, National Oilwell Varco, Varco, NOV, Companies, New York Stock Exchange, Economy of the United States, Service companies

National Oilwell Varco, Inc. (NYSE: NOV) will hold a conference call to discuss its first quarter 2019 results on Friday, April 26, 2019 at 10 a.m. (Central Time).

Key Points: 
  • National Oilwell Varco, Inc. (NYSE: NOV) will hold a conference call to discuss its first quarter 2019 results on Friday, April 26, 2019 at 10 a.m. (Central Time).
  • NOV will issue a press release with the Companys results after the market closes for trading on Thursday, April 25, 2019.
  • National Oilwell Varco (NYSE: NOV) is a leading provider of technology, equipment, and services to the global oil and gas industry that supports customers full-field drilling, completion, and production needs.
  • Since 1862, NOV has pioneered innovations that improve the cost-effectiveness, efficiency, safety, and environmental impact of oil and gas operations.

Resideo To Release Third Quarter Financial Results On Tuesday, Nov. 13 And Hold Its Investor Conference Call On Wednesday, Nov. 14

Retrieved on: 
Wednesday, November 7, 2018
Conference call, NOV

GOLDEN VALLEY, Minn., Nov. 7, 2018 /PRNewswire/ --Resideo Technologies, Inc. (NYSE: REZI) will issue its third quarter financial results after market close on Tuesday, Nov. 13.

Key Points: 
  • GOLDEN VALLEY, Minn., Nov. 7, 2018 /PRNewswire/ --Resideo Technologies, Inc. (NYSE: REZI) will issue its third quarter financial results after market close on Tuesday, Nov. 13.
  • The company will host a conference call and webcast with investors on Wednesday, Nov. 14 at 8:30 a.m. EST.
  • To join the conference call, please dial (866) 548-4713 (domestic) or +1 (323) 794-2093 (international) approximately ten minutes before the 8:30 a.m. EST start on Wednesday, Nov. 14.
  • Please mention to the operator that you are dialing in for Resideo's third quarter 2018 earnings call or provide the conference code 2572362.

Marathon Oil Schedules Third Quarter 2018 Earnings Release and Conference Call

Retrieved on: 
Wednesday, September 26, 2018
New York Stock Exchange, MRO, NOV, New York City

HOUSTON, Sept. 26, 2018 /PRNewswire/ --Marathon Oil Corporation (NYSE: MRO) announced today it plans to issue its third quarter 2018 earnings news release on Wednesday, Nov. 7, after the close of U.S. financial markets.

Key Points: 
  • HOUSTON, Sept. 26, 2018 /PRNewswire/ --Marathon Oil Corporation (NYSE: MRO) announced today it plans to issue its third quarter 2018 earnings news release on Wednesday, Nov. 7, after the close of U.S. financial markets.
  • The Company will conduct a conference call, which will be webcast live, on Thursday, Nov. 8, at 9 a.m.
  • ET.
  • All of the above information, including earnings releases and other investor-related material, can be accessed by visiting Marathon Oil's website at https://www.MarathonOil.com .

National Oilwell Varco selects Microsoft Dynamics 365 to enhance sales and service operations

Retrieved on: 
Wednesday, July 18, 2018
Economy, Business, ERP software, Accounting software, Business software, Application software, Cloud applications, National Oilwell Varco, Dynamics 365, Microsoft Dynamics, NOV, Varco

As oil and gas producers continue to push to optimize productivity and minimize downtime, NOV is leveraging Microsoft Dynamics 365 to streamline business processes, access real-time data and insights, and revolutionize field service operations with a digital, mobile-first approach.

Key Points: 
  • As oil and gas producers continue to push to optimize productivity and minimize downtime, NOV is leveraging Microsoft Dynamics 365 to streamline business processes, access real-time data and insights, and revolutionize field service operations with a digital, mobile-first approach.
  • Using Microsoft Dynamics 365 is enabling employees across NOV's departments to be more adaptable, reliable and efficient.
  • Microsoft Dynamics 365 unifies customer relationship management and enterprise resource planning solutions, allowing NOV's sales and commercial teams to effectively identify and capture field service opportunities and service managers to better allocate jobs and resources.
  • National Oilwell Varco, Inc. (NYSE: NOV) is a leading provider of technology, equipment, and services to the global oil and gas industry.

Renova Therapeutics Announces an Abstract to be Presented at the Late-Breaking Scientific Session of 2018 American Diabetes Association Meeting: Urocortin-2 Gene Transfer Effectively Treats Type 1 Diabetes

Retrieved on: 
Sunday, June 24, 2018
Endocrine system, Diabetes, Biology, Peptide hormones, Biotechnology, Insulin, Urocortin, Biopharmaceutical, NOV, Glucose uptake

Urocortin 2 gene-treated mice also exhibited improved insulin sensitivity, increased skeletal muscle glucose uptake, reduction in nephropathy and retinopathy, and a marked increase in survival.

Key Points: 
  • Urocortin 2 gene-treated mice also exhibited improved insulin sensitivity, increased skeletal muscle glucose uptake, reduction in nephropathy and retinopathy, and a marked increase in survival.
  • The poster is scheduled to be presented on Monday, June 25, 2018 from 12:00 pm 1:00 pm ET.
  • Renova Therapeutics is developing definitive, one-time gene therapies and peptide administration treatments to restore the health of people suffering from chronic diseases.
  • Renova Therapeutics was founded in 2009 and is led by an experienced management team in biopharmaceuticals and gene therapy.